FluMist: Clinical Trials

14 trials of FluMist, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

14 completed. 14 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	14	Completed 14
Phase 2	1	Completed 1

Follow FluMist: new trials by email Literature Review of FluMist trials Research Report on FluMist

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age Q/LAIV (MEDI3250), FluMist/B/Yamagata, FluMist/B/Victoria - Healthy or Stable Underlying Chronic Medical Condition	Phase 2 / Phase 3	Completed	MedImmune LLC	1800	2009-03-01	2011-12-05
Study To Evaluate the Safety of Bivalent Vaccine FluMist - Healthy	Phase 3	Completed	MedImmune LLC	300	2006-06-01	2007-07-18
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults FluMist - Healthy, Influenza	Phase 3	Completed	MedImmune LLC	300	2005-07-01	2007-05-09
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults FluMist, Placebo - Influenza	Phase 3	Completed	MedImmune LLC	300	2004-08-01	2007-12-18
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants CAIV-T, CAIVT, FluMist - Healthy	Phase 3	Completed	MedImmune LLC	890	2004-07-01	2007-11-27
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza Cold-adapted influenza vaccine trivalent (CAIV-T), Trivalent Inactivated Vaccine (TIV) - Influenza	Phase 3	Completed	MedImmune LLC	3009	2002-03-01	2012-03-14
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children. CAIV-T - Healthy	Phase 3	Completed	MedImmune LLC	2160	2002-03-01	2006-10-03
Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children. CAIV-T - Influenza	Phase 3	Completed	MedImmune LLC	2400	2001-09-01	2006-10-03
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) CAIV-T - Influenza	Phase 3	Completed	MedImmune LLC	120	2001-04-01	2021-09-13
Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older CAIV-T - Influenza	Phase 3	Completed	MedImmune LLC	3000	2001-04-01	2006-10-03
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children FluMist, Placebo - Influenza	Phase 3	Completed	MedImmune LLC	1200	2000-12-01	2008-02-08
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults CAIV-T - Influenza	Phase 3	Completed	MedImmune LLC	20	2000-11-01	2021-09-13
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers CAIV-T, Placebo - Influenza	Phase 3	Completed	MedImmune LLC	2903	2000-09-01	2009-04-10
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0) CAIV-T - Influenza	Phase 3	Completed	MedImmune LLC	200	1999-11-01	2006-10-25

Conditions studied

Sponsors

Countries

Top investigators

Results publications